FDA Investigator Daniel Lagasse
Daniel Lagasse has inspections in 1 countries as of 17 Oct 2023. Daniel Lagasse has collaborated with a combined 869 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
2
Last Inspection Date:
17 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Adam R Cooke,
Alicia Gilbert,
Alifiya H Ghadiali,
Andrew Chang,
Ann Marie Montemurro,
Ann Marie Schofield,
Carl Lee,
Christian D Lynch (CDL),
Christopher R Czajka,
Christopher S Keating,
Elmina E Akwo,
Ephrem Hunde, PhD,
Esther C Broner, PhD,
Gene D Arcy,
Gregory Price,
Helen B Ricalde,
Jacqueline Mdiaz Albertini,
James C Lee, PharmD,
Jeffrey M Watson,
Joseph George,
Julie D Bringger,
Kevin P Foley,
Latorie S Jones,
Linda Thai,
Mariza M Jafary,
Mihaly S Ligmond,
Nancy E Kirschbaum,
Nancy T Waites,
Omotunde O Osunsanmi,
Paula A Trost,
Prabhu P Raju,
Prajakta A Varadkar,
Ralph A Erickson,
Richard W Thornton,
Robert W Jennings,
Roman Drews, PhD,
Roman T Drews, PhD,
Seneca D Toms,
Simone E Pitts,
Song Y Lavalais,
Sonya M Edmonds,
Stephanie A Slater, MS,
Susan M Jackson,
Veronica Fuentes, MS,
Vijaya L Simhadri,
Viviana Matta,
Wendy G Tan, PhD,
Zuben E Sauna, PhD
Daniel Lagasse's Documents
Publish Date | Document Type | Title |
---|---|---|
November, 2019 | FDA 483 | Bayer HealthCare LLC - Form 483, 2019-11-21 |
November, 2019 | FDA 483 Response | Bayer HealthCare LLC - Form 483R, 2019-12-12 |
November, 2019 | EIR | Bayer HealthCare LLC - EIR, 2019-11-21 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more